The US Food and Drug Administration (FDA) has issued a warning against the use of 26 over-the-counter eye drop products.
The regulator asked consumers not to buy and to immediately stop using the products due to the risk of infections that could lead to partial vision loss or even blindness.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataPatients who have used the products should consult their healthcare provider or seek medical advice.
The medicines are offered under the brand names CVS Health, Leader (Cardinal Health), Rite Aid, Rugby (Cardinal Health), Target Up&Up and Velocity Pharma.
On 25 October 2023, the FDA recommended manufacturers to recall all the lots after regulatory investigators detected unsanitary conditions at manufacturing sites.
The investigators found positive results from bacterial tests conducted on samples taken at critical drug manufacturing areas.
The regulator asked consumers to carry out product disposals properly.
In a press statement, the FDA noted: “CVS, Rite Aid and Target are removing the products from their store shelves and websites.
“Products branded as Leader, Rugby and Velocity may still be available to purchase in stores and online and they should not be purchased.”
The FDA has not yet received reports of adverse events linked to the products’ usage.
